Literature DB >> 17682839

Aberrant expression and distribution of the OCT-4 transcription factor in seminomas.

Chien-Jui Cheng1, Yu-Chih Wu, Jye-An Shu, Thai-Yen Ling, Hung-Chih Kuo, Jui-Yu Wu, E E Chang, Shyh-Chern Chang, Yen-Hua Huang.   

Abstract

Testicular germ cell tumors (TGCTs), comprised of seminomas and non-seminomas, are derived from premalignant and noninvasive intracellular germ cell neoplasias. Among TGCTs, seminomas are believed to resemble a transformed state of primordial germ cells (PGCs) and are known to exhibit a gene expression profile similar to that of embryonic stem (ES) cells, such as transcription factor OCT-4. OCT-4 has recently been recognized as a diagnostic marker for clinical aspects of seminomas. However, the role of the OCT-4 protein in seminomas has not been clarified. To determine a possible role of the OCT-4 protein in seminomas, in this paper, we studied a series of 41 testicular tumor tissues and four cell lines by immunohistochemistry, Western blotting, and reverse-transcriptase polymerase chain reaction (RT-PCR) to examine the expression and distribution of the OCT-4 transcription factor in seminomas. By utilizing immunohistochemical staining and Western blotting, we demonstrated that the OCT-4 transcription factor was aberrantly localized in the cytoplasm and nuclei of cells in the collected seminoma tissues. This observation was further confirmed using immunocytochemical staining of NCCIT (seminoma-embryonal carcinoma) and NT2 (embryonal carcinoma) cells. In addition, the RT-PCR results indicated that Oct-4 mRNA was relatively highly expressed in NCCIT, NT2 cells, and seminoma tissues when compared with human embryonic stem cells. The aberrant expression and distribution of the OCT-4 transcription factor in seminomas may provide some important clues concerning the cell transformation between germ line stem cells (like PGC) and testicular germ cell tumors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17682839     DOI: 10.1007/s11373-007-9198-7

Source DB:  PubMed          Journal:  J Biomed Sci        ISSN: 1021-7770            Impact factor:   8.410


  4 in total

1.  Genome-wide analysis of OCT4 binding sites in glioblastoma cancer cells.

Authors:  Xue-feng Fang; Wei-yi Zhang; Na Zhao; Wei Yu; Dong Ding; Xu Hong; Li-sha Li; Hua-rong Zhang; Shu Zheng; Biao-yang Lin
Journal:  J Zhejiang Univ Sci B       Date:  2011-10       Impact factor: 3.066

2.  Clinical significance of POU5F1P1 rs10505477 polymorphism in Chinese gastric cancer patients receving cisplatin-based chemotherapy after surgical resection.

Authors:  Lili Shen; Mulong Du; Chun Wang; Dongying Gu; Meilin Wang; Qi Zhang; Tingting Zhao; Xunlei Zhang; Yongfei Tan; Xinying Huo; Weida Gong; Zhi Xu; Jinfei Chen; Zhengdong Zhang
Journal:  Int J Mol Sci       Date:  2014-07-18       Impact factor: 5.923

3.  The oncogene Gankyrin is expressed in testicular cancer and contributes to cisplatin sensitivity in embryonal carcinoma cells.

Authors:  Maria E Camacho-Moll; Joni Macdonald; L H J Looijenga; Michael P Rimmer; Roland Donat; John A Marwick; C J Shukla; Neil Carragher; Anne Jørgensen; Rod T Mitchell
Journal:  BMC Cancer       Date:  2019-11-19       Impact factor: 4.430

4.  Fermented Ginseng Extract, BST204, Suppresses Tumorigenesis and Migration of Embryonic Carcinoma through Inhibition of Cancer Stem Cell Properties.

Authors:  Jong Woo Park; Jee Hun Park; Jeung-Whan Han
Journal:  Molecules       Date:  2020-07-08       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.